0002032894-24-000001.txt : 20240812 0002032894-24-000001.hdr.sgml : 20240812 20240812162035 ACCESSION NUMBER: 0002032894-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240812 DATE AS OF CHANGE: 20240812 EFFECTIVENESS DATE: 20240812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sapere Bio, Inc. CENTRAL INDEX KEY: 0002032894 ORGANIZATION NAME: IRS NUMBER: 300785525 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-521292 FILM NUMBER: 241197077 BUSINESS ADDRESS: STREET 1: 400 PARK OFFICES DR., SUITE 113 CITY: DURHAM STATE: NC ZIP: 27709 BUSINESS PHONE: 919-904-4116 MAIL ADDRESS: STREET 1: 400 PARK OFFICES DR., SUITE 113 CITY: DURHAM STATE: NC ZIP: 27709 D 1 primary_doc.xml X0708 D LIVE 0002032894 Sapere Bio, Inc. 400 PARK OFFICES DR., SUITE 113 DURHAM NC NORTH CAROLINA 27709 919-904-4116 DELAWARE HealthSpan Diagnostics, LLC None Corporation true Natalia Mitin c/o Sapere Bio, Inc. 400 Park Offices Dr., Suite 113 Durham NC NORTH CAROLINA 27709 Executive Officer Director Biotechnology Decline to Disclose 06b false 2024-06-25 false true Simple Agreement for Future Equity false 0 2000000 500000 1500000 false 1 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Sapere Bio, Inc. /s/ Natalia Mitin Natalia Mitin Chief Executive Officer and President 2024-07-31